期刊文献+

α-晶状体蛋白的结构和功能及基因学研究进展 被引量:1

Recent research progress in the function,structure and genetics of alpha-crystallin
下载PDF
导出
摘要 α-晶状体蛋白包括αA-,αB-晶状体蛋白,是哺乳动物晶状体的主要蛋白,属于小热休克蛋白家族成员,具有分子伴侣功能,可以抑制变性蛋白质的凝聚和酶的失活。α-晶状体蛋白基因突变可导致白内障和肌病。本文对α-晶状体蛋白的分布、结构、功能以及基因学等方面综述。 Alpha-crystallin consists of two subunits: αA- and αB- crystalline, and is a major protein component of the mammalian eye lens. Being a member of the small heat-shock protein family, alpha-crystallin possesses chaperone-like function. It prevents aggregation of partially denatured proteins and the inactivation of enzymes. Mutations in alpha-crystallin genes can cause cataract and myopathy. This review focused on some of the expression, structure, function and genetics of alpha-crystallin.
出处 《国际眼科杂志》 CAS 2012年第7期1301-1303,共3页 International Eye Science
基金 军队医学杰出人才基金(No.04J011)~~
关键词 Α-晶状体蛋白 分子伴侣 基因学 白内障 alpha-crystallin molecular chaperones genetics cataract
  • 相关文献

参考文献30

  • 1Biswas A,Das KP. Alpha-crystallin assisted refolding of enzyme substrates:optimization of external parameters[J].PROTEIN JOURNAL,2007,(04):247-255.doi:10.1007/s10930-006-9066-8.
  • 2严宏,惠延年.α-晶体蛋白分子伴侣活性在白内障发病中作用的研究进展[J].眼科学报,2000,16(2):91-96. 被引量:15
  • 3严宏,惠延年,范建国,张延凤,武丽华,张晓楠.糖基化对α-晶状体蛋白的修饰和分子伴侣活性的降低[J].眼科新进展,2003,23(2):86-89. 被引量:18
  • 4严宏,惠延年,王建伟,王永强,丁正华,郭勇.高相对分子质量α-晶体蛋白分子伴侣活性在年龄相关性白内障中的变化[J].眼科研究,2006,24(1):5-8. 被引量:5
  • 5Gangadhariah MH,Wang B,Linetsky M. Hydroimidazolone modification of human αA-crystallin:Effect on the chaperone function and protein refolding ability[J].BBA-Molecular Basis of Disease,2010,(04):432-441.
  • 6Kerr BA,Byzova TV. αB-Crystallin:a novel VEGF chaperone[J].Blood,2010,(16):3398-3406.doi:10.1182/blood-2010-01-262766.
  • 7Horwitz J. Alpha-Crystallin[J].Experimental Eye research,2003,(02):145-153.doi:10.1016/S0014-4835(02)00278-6.
  • 8Ghahghaei A,Rekas A,Carver JA. Structure/function studies of dogfish alpha-crystallin,comparison with bovine alpha-crystallin[J].Molecular Vision,2009.2411-2420.
  • 9Horwitz J. Alpha-Crystallin:The quest for a homogeneous quaternary structure[J].Experimental Eye research,2009,(02):190-194.doi:10.1016/j.exer.2008.07.007.
  • 10Koteiche HA,McHaourab HS. Mechanism of a hereditary cataract Phenotype:mutations in alphaA-crystallin activate substrate binding[J].Biological Chemistry,2006,(20):14273-14279.

二级参考文献20

  • 1严宏,惠延年,李明勇,张延凤,张晓楠,武丽华.α-晶状体蛋白分子伴娘功能的初步研究[J].中华眼科杂志,2004,40(8):559-560. 被引量:2
  • 2严宏 张东杲 等.α-晶体蛋白作粉娘对糖基化诱导过氧化氢酶失活的保护[J].第四军医大学学报,1998,1:33-33.
  • 3Yan H, Harding JJ, Hui YN, et al. Decreased chaperone activity of alpha-crystallin in selenite cataract may result from selenite-induced aggregation[J]. Eye, 2003,17(5):637 - 645.
  • 4Fujii N, Awakura M, Takemoto L, et al. Characterization of alpha A-crystallin from high molecular weight aggregates in the normal human lens[J]. Mol Vis,2003,9: 315 - 322.
  • 5Derham BK,Harding JJ. Effect of aging on the chaperone-like function of human a-crystallin assessed by three methods[J]. Biochem J, 1997,328:763 - 768.
  • 6Horwitz J. Alpha-crystallin can function as a molecular chaperone[J]. Proc Natl Acad Sci USA, 1992,89:10449 -10461.
  • 7Derham BK, Harding JJ. Alpha-crystallin as a molecular chaperone [J].Prog Retin Eye Res, 1999,18 (4) : 463 - 509.
  • 8Carver JA, Nicholls KA,Aquilina JA, et al. Age-related changes in bovine a-crystallin and high-molecular-weight protein [J]. Exp Eye Res, 1996,63:639 - 647.
  • 9Liang JJ, Akhtar NJ. Human lens high-molecular-weight alpha-crystallin aggregates [J]. Biochem Biophys Res Commun ,2000 ,275 ( 2 ) : 354 - 359.
  • 10Raza K, Harding JJ. Non-enzymic modification of lens proteins by glucose and fructose: effects of Ibuprofen [J]. Exp Eye Res 1991;52:205-212.

共引文献33

同被引文献34

  • 1祁磊,林媛.年龄相关性白内障的防治进展[J].海峡科学,2010(5):51-53. 被引量:3
  • 2魏湘铭,魏冠男.复明片治疗未成熟期老年性白内障临床观察[J].国际眼科杂志,2007,7(1):277-279. 被引量:4
  • 3葛坚.眼科学[M].第2版.北京:人民卫生出版社,2013:185-186.
  • 4Bahrami M, Goncharov AV, Pierscionek BK. Adjustable internal structure for reconstructing gradient index profile of crystalline [ J ]. Opt Lett,2014 ; 39(5) :1310-3.
  • 5Zuercher J, Neidhardt J, Magyar I,et al. Alterations of the 5 "untranslated region of SLC16A12 lead to age-related cataract [ J ]. Invest Ophthalmol Vis Sci ,2010 ;51 (7) :3354-61.
  • 6Babizhavev MA, Vishnyakova KS, Yegorov YE. Oxidativve damage im- pact on aging and age-related diseases: drug targeting of telomere attri- tion and dynamictelomerase activity flirting with imidazole-containing dipeptides [ J ]. Recent Pat Drug Deliv Formul, 2014 ; 8 ( 3 ) : 163 -92.
  • 7Babizhavev MA, Yegorov YE. Biomarkers of oxidative stree and cata- ract. Novel drug delivery therapeutic strategies targeting telomerereduc- tion and the expression of telomerase activity in the lens epithelial ceils with N-acetylcarnosine lubricant eye drops:anti-cataract which helps to prevent and treat cataracts in the eyes of dogs and other animals [ J ]. Curr Drug Deliv,2014 ;11 ( 1 ) :2-61.
  • 8Sanders JL, Lannaccone A, Boudreau RM, et al. The association of cata- ract with leukocyte telomere length in older adulrs : defining a new mark- er of aging[ J]. J Gerontol A Biol Sci MED Sci ,2011 ;66 (6) :639-45.
  • 9Grzybowski A, Ascaso FJ. Sushruta in 600 B. C. introdhced extraocular expulsion of lens material[ J ]. Acta Ophthalmo1,2014 ;92 (2) : 194-7.
  • 10Yip JL, Nolan WP, Gilbert CE, et al. Prophylactic laser peripheral iridot- omy and cataract progression[ J ]. Eye (Lond) ,2010 ;24 ( 7 ) : 1127-34.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部